|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
CA200-003 KAG-302, NCT00514371
|
|
|
|
|
|
|
|
Last Modified: 3/20/2007  First Published: 6/23/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
Any age
|
|
|
|
NCI
|
|
|
|
MSKCC-04056 NCI-6480, 6480, NCT00087386
|
|
|
|
|
|
|
|
Last Modified: 10/26/2007  First Published: 9/25/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MSKCC-04082 6479, NCI-6479, NCT00093405
|
|
|
|
|
|
|
|
Last Modified: 8/23/2008  First Published: 10/25/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
WSU-C-2803 6552, NCI-6552, NCT00096109
|
|
|
|
|
|
|
|
Last Modified: 4/2/2008  First Published: 2/18/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
CRUK-PH2/049 6500, NCI-6500, NCT00104897
|
|
|
|
|
|
|
|
Last Modified: 7/31/2006  First Published: 6/25/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MAYO-MC0453 NCI-6651, 6651, NCT00118092
|
|
|
|
|
|
|
|
Last Modified: 6/23/2008  First Published: 8/12/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NCI-06-C-0076 6454, NCI-6454, NCI-P6175, NCT00132015
|
|
|
|
|
|
|
|
Last Modified: 10/26/2007  First Published: 8/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 to 75
|
|
|
|
Other
|
|
|
|
CRC-PHASE-I-PH1/074 NCI-T99-0013, EU-99055, NCT00003969, T99-0013
|
|
|
|
|
|
|
|
Last Modified: 4/7/2005  First Published: 10/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MSKCC-99037 NCI-T99-0035, UCLA-0206019, NCT00004065, T99-0035
|
|
|
|
|
|
|
|
Last Modified: 8/31/2005  First Published: 10/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MAYO-990102 NCI-T99-0058, NCT00004075, T99-0058
|
|
|
|